leisure time -WSS

leisure time

author：entertainment 2025-09-27 14:01:48 - browse：41

Sen. Ron Wyden, D-Ore., left, and Sen. Mike Crapo, R-Idaho, right, walk on Capitol Hill. -- health policy coverage from STAT — Sen. Ron Wyden, D-Ore., left, and Sen. Mike Crapo, R-Idaho, right, walk on Capitol Hill in 2021. Susan Walsh/AP

WASHINGTON — One of the top health care committees in the Senate is assembling ideas for bipartisan legislation to address drug shortages, three Senate aides and three lobbyists told STAT.

The talks, led by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho) are in the early days, but they could move the debate over drug shortage reforms into a new phase. The committee has jurisdiction over Medicare and Medicaid payment policies for hospitals. Other committees that have tried tackling the issue have jurisdiction mostly over the Food and Drug Administration.

The panel is tentatively aiming to hold a hearing on the issue in November, the sources said. The panel has also started accepting input from outside stakeholders, one lobbyist said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Susan Tousi leaves Illumina to head cancer liquid biopsy startup

WSS

Why psychiatrists like me stop taking insurance

Colonoscopy at 40? Study finds a possible benefit

J&J to buy cancer drug developer Ambrx Biopharma

Ask STAT: What do you want to know about ChatGPT in medicine?

Why we need to separate burnout from moral injury in health care

Disclosing genetic information: not as worrisome as once feared

focus

leisure time

focus

Trump demands the U.S. pay no more for drugs than other countries … again

Weight bias in eating disorder treatment complicated by new weight loss drugs

Drug repurposing or repositioning? The language matters

Goldman Sachs launches $650M fund for life science investments

Guidelines to prevent youth baseball injuries need more muscle

Cloning humans is technically possible. It's curious no one has tried

Heart attack and stroke risk calculators need revising

Goldman Sachs launches $650M fund for life science investments

Jerome Adams on the need for new antivirals for Covid

Antibiotic resistance and the global rise in human conflict

knowledge

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

Death of patient in Alzheimer’s trial raises question of possible risks

How a scoliosis diagnosis changed the life of one young dancer

Disclosing genetic information: not as worrisome as once feared

Why are elite athletes different? Take a look at their microbes

explore

entertainment

focus

Wikipedia